近日,诺和诺德召开全球媒体沟通会。诺和诺德公司全球总裁兼CEO杜麦克(Mike Doustdar)、首席科学官Martin Holst Lange、产品与产品组合战略全球执行副总裁周虹及国际运营部执行副总裁林意明(Emil Kongshj Larsen)等集体出席,围绕核心分子司美格鲁肽的战略定位、口服制剂的全球部署以及管线与并购的推进逻辑,作出系统阐述。 在司美格鲁肽美国核心化合物专利将到期、...
Source Link近日,诺和诺德召开全球媒体沟通会。诺和诺德公司全球总裁兼CEO杜麦克(Mike Doustdar)、首席科学官Martin Holst Lange、产品与产品组合战略全球执行副总裁周虹及国际运营部执行副总裁林意明(Emil Kongshj Larsen)等集体出席,围绕核心分子司美格鲁肽的战略定位、口服制剂的全球部署以及管线与并购的推进逻辑,作出系统阐述。 在司美格鲁肽美国核心化合物专利将到期、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.